September 2023 Norton Medical Group new providers
Paul A. Adams, M.D. Emergency Medicine Matthew P. Allinder, M.D. Emergency Medicine Austin C. Baker, M.D. Emergency Medicine Jared S. Bass, D.O. Emergency Medicine Shannon M. Becht, M.D. Emergency Medicine Kristen Bublitz, D.O. Emergency Medicine […]
View more
Shawn W. Adams, M.D., joins Norton Leatherman Spine
After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity [...]
View more
November 2023 Norton Children’s Medical Group New Providers
Christie Buonpane, M.D. Pediatric General Surgery Claire E. Milligan, Ph.D. Pediatric Psychology Kathryn R. Gallegos, APRN Pediatric Neurology Austin Peters, APRN Pediatrics Corinne M. Streble, APRN Pediatric Cardiology
View more
November 2023 Norton Medical Group new providers
George Gad, M.D. Hospital Medicine Nathan Gonda, D.O. Emergency Medicine Sarah B. Radtke, M.D. Obstetrics/ Gynecology Lauren M. Strait, M.D. Vascular Surgery Molly E. Tuller, M.D. Obstetrics/Gynecology Tracey D. Wolford, M.D. Gastroenterology Maureen Carberry, PA-C […]
View more
Tzield may delay Stage 3 Type 1 diabetes in adults and children
Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and […]
View more
Ultra-fast-acting inhaled insulin, Afrezza, trialed at Norton Children’s Endocrinology
Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton […]
View more
DFMO medulloblastoma clinical trial examines drug’s effectiveness for high-risk cases
Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric [...]
View more
Butyrate-producing gut bacteria a promising avenue for Alzheimer’s treatment
Butyrate-producing gut bacteria are a promising target for preventing and treating memory loss associated with Alzheimer’s disease, according to research presented recently at the Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The research in […]
View more
Norwood vs. COMPSII for critical left heart obstruction with prior palliation
Surgeons face two choices for infants with critical left heart obstruction who have had prior hybrid palliation: a Norwood operation or a comprehensive stage II (COMPSII). The critical left heart obstruction cohort of the multi-institutional […]
View more
Natural killer cell leukemia trial underway
A human Phase 1 immunotherapy clinical trial is underway using natural killer cells, or NK cells, to target relapsed or refractory acute myeloid leukemia. Acute myeloid leukemia patients who have exhausted other treatment options are [...]
View more
October 2023 Norton Children’s Medical Group New Providers
Rachel L. Evans, M.D. Pediatric Neurology Stephanie M. Green, D.O. Pediatric Physical Medicine and Rehabilitation Kelly A. Jenkins, M.D. Pediatric Orthopedic Surgery Michael S. Orangias, M.D. Pediatric Pulmonology, Pediatric Sleep Medicine Huma […]
View more
October 2023 Norton Medical Group new providers
Jonathan P. Boland, M.D. Emergency Medicine James C. Gray IV, M.D. Emergency Medicine Stephanie Miles, M.D. Family Medicine Vladimir Pulgaron, M.D. Family Medicine Steven J. Radtke, M.D. Urogynecology Cindy Truong, D.O. Internal Medicine Michael McCool […]
View more